GLP3 (Reta) — Triple-Receptor Metabolic Research Peptide
An investigational triple-receptor agonist and one of the most closely watched compounds in modern metabolic research. Each Vitalyx Bio vial contains 10 mg of Reta as a lyophilized powder, supplied strictly for in-vitro and laboratory research.
Research Pathways
- GLP-1 Receptor Engagement — studied for effects on incretin signaling and glucose-dependent insulin response pathways.
- GIP Receptor Co-Agonism — investigated alongside GLP-1 activity for combined incretin-pathway effects.
- Glucagon Receptor Activity — the third arm of the triple-agonist design, examined for its role in energy-expenditure signaling.
- Appetite & Energy-Balance Signaling — studied in hypothalamic and peripheral models for satiety-related pathway activity.
Where the Research Stands
Triple-receptor agonists represent a newer generation of metabolic research compounds, building on single- and dual-agonist peptide research. Reta’s three-receptor design has made it a frequent reference point in published research examining how combined incretin and glucagon signaling affects glucose regulation and lipid metabolism relative to earlier single-pathway compounds.
Reconstitution & Storage
Store the sealed, lyophilized vial cool, dry, and protected from light. Reconstitute with bacteriostatic water, added slowly down the vial wall. Once reconstituted, store refrigerated at 2–8°C, minimize light exposure, and avoid repeated freeze–thaw cycles. Defer to your laboratory’s standard handling protocols for aseptic technique and disposal.
This product is sold strictly for laboratory research use only. Not for human use, consumption, or therapeutic application.
